PF-Atlas › Clinical Trials › NCT04677426

129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study

Hyperpolarized Xe129 · Phase 2

Registry ID
NCT04677426
Phase
Phase 2
Status
Withdrawn
Drug / intervention
Hyperpolarized Xe129
Sponsor
University of Kansas Medical Center
Start
2022-05-01

About this trial

This research is a study to test the reliability of Hyperpolarized Xenon MRI (HXe MRI) as a biomarker in interstitial lung disease. The study is a non-randomized study to evaluate the test-retest performance of HXe MRI in Idiopathic Pulmonary Fibrosis (IPF) and chronic Hypersensitivity Pneumonitis (cHP) as a non-invasive biomarker of disease severity and prognosis. The study will include approximately 15 subjects with IPF, 15 subjects with cHP and 10 sex and age-matched normal controls performed across 3 sites.

View NCT04677426 on ClinicalTrials.gov →

Explore related

All Hyperpolarized Xe129 trialsAll IPF trials

Related trials

Hyperpolarized Xe129 — NCT06853145Hyperpolarized Xe129 — NCT04624490
Medical disclaimer. This page summarizes public trial data for NCT04677426 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.